Tesamorelin is a synthetic peptide analogue of growth hormone-releasing hormone (GHRH). It has been studied for its interaction with GHRH receptors and its downstream effects on growth hormone and insulin-like growth factor signalling. In research settings, tesamorelin is commonly used to investigate endocrine signalling, peptide-receptor interactions, metabolic pathways, and growth hormone axis regulation.

• GHRH receptor activation studies
• Growth hormone signalling pathway research
• IGF-1 pathway expression analysis
• Metabolic and lipid signalling models
• Endocrine feedback and receptor-response studies

This product has not been evaluated by SAHPRA and is not intended to diagnose, treat, cure, or prevent any disease. For research use only. Not for human or animal consumption. Not a drug, food additive, cosmetic, or dietary supplement.